HuMax-CD20

ofatumumab · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for HuMax-CD20, covering 2011-11-29 to 2015-04-21. Get the full timeline:

Most recent: Clinical Trial Update: HuMax-CD20 in Chronic Lymphocytic Leukemia [Phase 1, Phase 2]